Cargando…

Chronic myeloid leukemia stem cells: targeting therapeutic implications

Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasm driven by BCR-ABL1 oncoprotein, which plays a pivotal role in CML pathology, diagnosis, and treatment as confirmed by the success of tyrosine kinase inhibitor (TKI) therapy. Despite advances in the development of more potent tyro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mojtahedi, Hanieh, Yazdanpanah, Niloufar, Rezaei, Nima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684082/ https://www.ncbi.nlm.nih.gov/pubmed/34922630 http://dx.doi.org/10.1186/s13287-021-02659-1

Ejemplares similares

Immune-based therapeutic approaches in COVID-19
por: Moeinafshar, Aysan, et al.
Publicado: (2022)

Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells
por: Hamad, Ahmad, et al.
Publicado: (2013)

Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer
por: Fayyaz, Farimah, et al.
Publicado: (2022)

Safety and efficacy of T-cell-redirecting bispecific antibodies for patients with multiple myeloma: a systematic review and meta-analysis
por: Noori, Maryam, et al.
Publicado: (2023)

The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
por: Heidari, Arash, et al.
Publicado: (2022)

Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells
por: Houshmand, Mohammad, et al.
Publicado: (2021)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

Leukemia stem cells: the root of chronic myeloid leukemia
por: Zhou, Hong, et al.
Publicado: (2015)

Chronic myeloid leukemia stem cells
por: Houshmand, Mohammad, et al.
Publicado: (2019)

Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?
por: Soverini, Simona, et al.
Publicado: (2021)

The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia
por: Wu, Andrew, et al.
Publicado: (2023)

Loneliness: An Immunometabolic Syndrome
por: Pourriyahi, Homa, et al.
Publicado: (2021)

Acute Myeloid Leukemia Mutations: Therapeutic Implications
por: Papayannidis, Cristina, et al.
Publicado: (2019)

Lysosomes in Stem Cell Quiescence: A Potential Therapeutic Target in Acute Myeloid Leukemia
por: Jain, Vaibhav, et al.
Publicado: (2022)

Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
por: Mohamed, Kawthar, et al.
Publicado: (2021)

Cognitive Biases Affecting the Maintenance of COVID-19 Pandemic
por: Mohamed, Kawthar, et al.
Publicado: (2021)

Leukemia Stem Cells as a Potential Target to Achieve Therapy-Free Remission in Chronic Myeloid Leukemia
por: Ito, Kyoko, et al.
Publicado: (2021)

Molecular signatures of chronic myeloid leukemia stem cells
por: Chen, Yaoyu, et al.
Publicado: (2013)

Therapeutic use of Aldara™ in chronic myeloid leukemia
por: Marleau, Annette M, et al.
Publicado: (2007)

Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia
por: Muselli, Fabien, et al.
Publicado: (2019)

The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting
por: Chen, Yongfeng, et al.
Publicado: (2022)

Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia
por: Parting, Oliver, et al.
Publicado: (2020)

Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation
por: Mulas, Olga, et al.
Publicado: (2022)

Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin
por: Gottardi, Michele, et al.
Publicado: (2021)

Nuclear Receptors as Potential Therapeutic Targets for Myeloid Leukemia
por: Pan, Pan, et al.
Publicado: (2020)

Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy
por: Carrà, Giovanna, et al.
Publicado: (2019)

New Developments in Chronic Myeloid Leukemia: Implications for Therapy
por: Tabarestani, Sanaz, et al.
Publicado: (2016)

CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia
por: Yakymiv, Yuliya, et al.
Publicado: (2019)

RhoA: A therapeutic target for chronic myeloid leukemia
por: Molli, Poonam R, et al.
Publicado: (2012)

Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities
por: Stahl, Maximilian, et al.
Publicado: (2016)

NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
por: Sportoletti, Paolo, et al.
Publicado: (2021)

Chronic Myeloid Leukemia Stem Cell Biology
por: Crews, Leslie A., et al.
Publicado: (2012)

Stem Cell Biomarkers in Chronic Myeloid Leukemia
por: Jiang, Xiaoyan, et al.
Publicado: (2008)

Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia
por: Aitken, Marisa J. L., et al.
Publicado: (2021)

Targeting acute myeloid leukemia stem cell signaling by natural products
por: Siveen, Kodappully Sivaraman, et al.
Publicado: (2017)

Lysosomes in acute myeloid leukemia: potential therapeutic targets?
por: Rafiq, Sreoshee, et al.
Publicado: (2021)

Treatment-Free Remission in Chronic Myeloid Leukemia and New Approaches by Targeting Leukemia Stem Cells
por: Chen, Yilin, et al.
Publicado: (2021)

Development and targeted use of nilotinib in chronic myeloid leukemia
por: Fava, Carmen, et al.
Publicado: (2009)

Targeted treatment of chronic myeloid leukemia: role of imatinib
por: Tamascar, Ila, et al.
Publicado: (2009)

Current status of hematopoietic stem cell transplant in chronic myeloid leukemia
por: Gupta, Alok, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tgeu8ml7bvueumsmsc3acivgtj